Juanjuan Du

Dr. Juanjuan Du

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2021 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
LHLei He
Lei He
LWLiangliang Wang
Liangliang Wang
ZWZhisong Wang
Zhisong Wang
TLTiantian Li
Tiantian Li
HCHui Chen
Hui Chen
XLXuebin Liao
Xuebin Liao

2 July 2024 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
MZMing Zhu
Ming Zhu
RXRunda Xu
Runda Xu
JYJunsong Yuan
Junsong Yuan
JWJiacheng Wang
Jiacheng Wang
XRXiaoyu Ren
Xiaoyu Ren
XLXun Lan
Xun Lan

27 June 2023 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
YZYan Zhao
Yan Zhao
HJHaolin Jiang
Haolin Jiang
JYJiazhen Yu
Jiazhen Yu
LWLuyao Wang
Luyao Wang
JDJuanjuan Du
Juanjuan Du

17 November 2022 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
RLRu Li
Ru Li
TLTiantian Li
Tiantian Li
GLGenzhe Lu
Genzhe Lu
ZCZhi Cao
Zhi Cao
BCBowen Chen
Bowen Chen
PLPilong Li
Pilong Li

16 May 2018 in Nano Research
Verified
Journal Article
Closed access
PDF file
XJXiangqian Jia
Xiangqian Jia
LWLuyao Wang
Luyao Wang
JDJuanjuan Du
Juanjuan Du
Biopharmaceuticals, including proteins, DNAs, and RNAs, hold vast promise for the treatment of many disorders, such as cancer, diabetes, autoimmune diseases, infectious diseases, and rare diseases. The application of biopharmaceuticals, however, is limited by their poor stability, immunogenicity, suboptimal pharmacokinetic performance, undesired tissue distribution, and low penetration through biological barriers. In situ polymerization provides an appealing and promising platform to improve the pharmacological characteristics of biopharmaceuticals. Instead of the traditional “grafting to” polymer–biomolecule conjugation, in situ polymerization grows polymers on the surfaces of the biomacromolecules, resulting in easier purification procedures, high conjugation yields, and unique structures. Herein, this review surveys recent advances in the polymerization methodologies. Additionally, we further review improved therapeutic performance of the resultant nanomedicines. Finally, the opportunities, as well as the challenges, of these nanocomposites in the biomedical fields are discussed. Open image in new window

21 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
LWLuyao Wang
Luyao Wang
WZWen Zhou
Wen Zhou
HCHang Chen
Hang Chen
XJXiangqian Jia
Xiangqian Jia
PZPeiyuan Zheng
Peiyuan Zheng
JDJuanjuan Du
Juanjuan Du
Targeted protein delivery with nanocarriers holds significant potential to enhance therapeutic outcomes by precisely directing proteins to specific organs or tissues. However, the complex interactions between nanocarriers and the biological environment pose considerable challenges in designing effective targeted delivery vehicles. In this study, we address this challenge by leveraging DNA-barcoded high-throughput screening. We construct a nanocapsule library via in-situ polymerization, incorporating various monomers to create nanocapsules with unique surface properties. In vitro and in vivo screening, using female mice, identify nanocapsules with high cell association and different biodistribution. Our investigation into kidney-enriched nanocapsules highlights the crucial role of polymer composition in biodistribution, demonstrating the potential of surface engineering for precise control over nanoparticle distribution. The kidney-enriched nanocapsule successfully delivers catalase, showcasing its therapeutic potential in mitigating cisplatin-induced acute kidney injury. Overall, our study presents an approach for identifying protein delivery vehicles, with the capacity to broaden the application of proteins as therapeutic agents or research tools.